First-line diuretics versus other classes of antihypertensive drugs for hypertension

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Wright, James M ^a   Musini, Vijaya M ^a   Salzwedel, Douglas M ^a   Dormuth, Colin ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

ADVERSE OUTCOME; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; DIASTOLIC BLOOD PRESSURE; DIURETIC THERAPY; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; HEART INFARCTION; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; REVIEW; STROKE; SUDDEN DEATH; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 77950112488     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008161     Document Type: Review

References (12)

1. Collins 1990 Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al.Blood pressure, stroke and coronary heart disease - part 2, short term reduction in blood pressure: overview of randomised drug trials in epidemiological context. Lancet 1990;335:827-38.
2. Gueyffier 1996 Gueyffier F, Froment A, Gouton M. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. J Hum Hypertens 1996;10:1-8.
3. Insua 1994 Insua JT, Sacks HS, Lau TS, Lau J, Reitman D, Pagano D, Chalmers T. Drug treatment of hypertension in the elderly: A meta-analysis. Ann Intern Med 1994;121:355-62.
4. IPPSH 1985 IPPSH collaboration group. Cardiovascular risk and risk factors in a randomized trial of beta blocker, oxeprenolol: The International Prospective Primary Prevention study in hypertension (IPPSH). Hypertension 1985;3:379-392.
5. MacMahon 1993 MacMahon S, Rogers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in the elderly hypertensives. Clin Exper Hypertension 1993;15:967- 78.
6. Mulrow 1994 Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly: Implications and generalizability of randomized trials. JAMA 1994;272:1932-8.
7. Mulrow 1998 Mulrow C, Lau J, Cornell J, Brand M. Pharmacotherapy for hypertension in the elderly. Cochrane Database of Systematic Reviews 1997, Issue 4. [DOI: 10.1002/14651858.CD000028]
8. Psaty 1997 Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Hechbert SR, Lemaitre RN, Wagner EH, Furberg CD. Health outcomes associated with antihypertensive therapies used as first line agents. A systematic review and meta-analysis. JAMA 1997; 277:739-45.
9. Psaty 2003 Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS. Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-analysis. JAMA 2003;289:2534-2544.
10. Thijs 1992 Thijs L, Fagard R, Lijnen P, Staessen J, VanHoof R, Amery A. A meta-analysis of outcome trials in elderly hypertensives. J Hypertens 1992;10:1103-9.
11. Wright 2009 Wright JM, Musini VM. First-line drugs for hypertension. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI:10.1002/14651858.CD001841.pub2]
12. Wright 1999 Wright JM, Lee CH, Chambers GK. Systematic review of antihypertensive therapies: Does the evidence assist in choosing a firstline drug?. Canadian Medical Association Journal 1999;161:25-32.